RT Journal Article
SR Electronic
T1 Reproducibility and reporting practices in COVID-19 preprint manuscripts
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.24.20042796
DO 10.1101/2020.03.24.20042796
A1 Josh Sumner
A1 Leah Haynes
A1 Sarah Nathan
A1 Cynthia Hudson-Vitale
A1 Leslie D. McIntosh
YR 2020
UL http://medrxiv.org/content/early/2020/03/27/2020.03.24.20042796.abstract
AB The novel coronavirus, COVID-19, has sparked an outflow of scientific research seeking to understand the virus, its spread, and best practices in prevention and treatment. If this international research effort is going to be as swift and effective as possible, it will need to rely on a principle of open science. When researchers share data, code, and software and generally make their work as transparent as possible, it allows other researchers to verify and expand upon their work. Furthermore, it allows public officials to make informed decisions. In this study, we analyzed 535 preprint articles related to COVID-19 for eight transparency criteria and recorded study location and funding information. We found that individual researchers have lined up to help during this crisis, quickly tackling important public health questions, often without funding or support from outside organizations. However, most authors could improve their data sharing and scientific reporting practices. The contrast between researchers’ commitment to doing important research and their reporting practices reveals underlying weaknesses in the research community’s reporting habits, but not necessarily their science.Competing Interest StatementAll authors are employed by Ripeta.Funding StatementNo funding was provided for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and code are available on figshare. Data: 10.6084/m9.figshare.12026364 Code: 10.6084/m9.figshare.12026370 https://figshare.com/articles/Covid_Preprint_Data/12026364 https://figshare.com/articles/Covid_Preprint_-_R_Code/12026370